出版应用/物种/样本/稀释 | 参考文献 |
---|
| Beddingfield B, Iwanaga N, Zheng W, Roy C, Hu T, Kolls J, et al. The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection. bioRxiv. 2020;: pubmed 出版商
|
| Amruta N, Maness N, Gressett T, Tsuchiya Y, Kishi M, Bix G. Effect of acetic acid inactivation of SARS-CoV-2. PLoS ONE. 2023;18:e0276578 pubmed 出版商
|
| Wang Z, An J, Liu K, Yu P, Fang X, Li J, et al. A potent, broadly protective vaccine against SARS-CoV-2 variants of concern. NPJ Vaccines. 2022;7:144 pubmed 出版商
|
| Song J, Chow R, Pe xf1 a Hern xe1 ndez M, Zhang L, Loeb S, So E, et al. LRRC15 inhibits SARS-CoV-2 cellular entry in trans. PLoS Biol. 2022;20:e3001805 pubmed 出版商
|
| Wang R, Huang X, Cao T, Sun C, Luo D, Qiu H, et al. Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants. Virology. 2022;576:61-68 pubmed 出版商
|
| Liu H, Kaku C, Song G, Yuan M, Andrabi R, Burton D, et al. Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron. Commun Biol. 2022;5:766 pubmed 出版商
|
| Fang Z, Peng L, Filler R, Suzuki K, McNamara A, Lin Q, et al. Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2. bioRxiv. 2022;: pubmed 出版商
|
| Bao L, Zhang C, Lyu J, Yi P, Shen X, Tang B, et al. Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker. J Appl Microbiol. 2022;132:2421-2430 pubmed 出版商
|
| Shalash A, Azuar A, Madge H, Modhiran N, Amarilla A, Liang B, et al. Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay. Vaccines (Basel). 2021;9: pubmed 出版商
|
| Song J, Chow R, Pena Hernandez M, Zhang L, Loeb S, So E, et al. LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans. bioRxiv. 2021;: pubmed 出版商
|
| Liu H, Zhou C, An J, Song Y, Yu P, Li J, et al. Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants. Vaccine. 2021;39:7001-7011 pubmed 出版商
|
| Huang C, Tan Z, Zhao K, Zou W, Wang H, Gao H, et al. The effect of N-glycosylation of SARS-CoV-2 spike protein on the virus interaction with the host cell ACE2 receptor. iScience. 2021;24:103272 pubmed 出版商
|
| Han S, Zhao G, Wei Z, Chen Y, Zhao J, He Y, et al. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade. Peptides. 2021;145:170638 pubmed 出版商
|
| Du P, Chou Y, Santos H, Keskin B, Hsieh M, Ho T, et al. Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis. Anal Chem. 2021;93:7690-7698 pubmed 出版商
|
| Wang C, Wang S, Li D, Chen P, Han S, Zhao G, et al. Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone. ACS Infect Dis. 2021;7:1545-1554 pubmed 出版商
|
| Kim K, Bhatnagar N, Jeeva S, Oh J, Park B, Shin C, et al. Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice. Vaccines (Basel). 2021;9: pubmed 出版商
|
| Rappazzo C, Tse L, Kaku C, Wrapp D, Sakharkar M, Huang D, et al. An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19. bioRxiv. 2020;: pubmed 出版商
|
| McCallum M, Walls A, Bowen J, Corti D, Veesler D. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat Struct Mol Biol. 2020;27:942-949 pubmed 出版商
|